POZEN Inc. (NASDAQ:POZN – News), a pharmaceutical company committed to transforming medicine that transforms lives, presented data today from a Phase 1 study that found that the investigational compound, PA32540, provides faster protection …
Shouguang Fukang Pharmaceutical Co., Ltd.
Trimethoprim|TMP|Omeprazole|Sulfamethoxazole|SMZ|Metformin HCl|Bromide compounds